Response to: “Intact Excision of Breast Lesions Using BLES™: Is There a Clinical Indication Yet?”
- 1 Downloads
To the Editors:
In response to our article1, in her editorial2 Yao states that a second procedure was needed to achieve clear margins in 27% of patients: “Of 124 cancer patients, 55% had clear margins after undergoing a biopsy with the BLES device, 27% underwent another procedure with the BLES device to establish negative margins”. She repeats this error when summarizing the results in cancer patients: “In the current study, 55% of cancerous lesions (DCIS and invasive carcinoma) had complete excision, with one procedure using the BLES device, and 45% of patients had to undergo another procedure, either with the BLES device or surgical excision”.
In our article, we clearly state that patients having excision of small cancers had one procedure: “Patients with DCIS or invasive cancers (recent diagnostic biopsy with core or Intact device) had an MI excision procedure that included a second Intact capture to provide a shaved margin. All such patients were registered”. Therefore, the...